GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...

Quick Custom Intelligence (QCI) continues its rapid expansion, now operating in 17 countries while actively developing business opportunities in 10 additional markets. This growth, combined with QCI’s ...